BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 24777850)

  • 1. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
    de Wilde MA; Veltman-Verhulst SM; Goverde AJ; Lambalk CB; Laven JS; Franx A; Koster MP; Eijkemans MJ; Fauser BC
    Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
    Veltman-Verhulst SM; Goverde AJ; van Haeften TW; Fauser BC
    Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome.
    Veltman-Verhulst SM; van Haeften TW; Eijkemans MJ; de Valk HW; Fauser BC; Goverde AJ
    Hum Reprod; 2010 Dec; 25(12):3123-8. PubMed ID: 20943702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
    Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.
    De Frène V; Vansteelandt S; T'Sjoen G; Gerris J; Somers S; Vercruysse L; De Sutter P
    Hum Reprod; 2014 Oct; 29(10):2333-8. PubMed ID: 24963163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
    Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
    Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.